Alteration of splicing factors' expression during liver disease progression: impact on hepatocellular carcinoma outcome.
Wang H, Lekbaby B, Fares N, Augustin J, Attout T, Schnuriger A, Cassard AM, Panasyuk G, Perlemuter G, Bieche I, Vacher S, Selves J, Péron JM, Bancel B, Merle P, Kremsdorf D, Hall J, Chemin I, Soussan P.
Wang H, et al. Among authors: bieche i.
Hepatol Int. 2019 Jul;13(4):454-467. doi: 10.1007/s12072-019-09950-7. Epub 2019 May 28.
Hepatol Int. 2019.
PMID: 31140152